Investment Rating - The report maintains a "Positive" rating for the chemical industry [5][6][20] Core Insights - The petrochemical industry is expected to see stable growth due to the introduction of policies aimed at enhancing industry health and eliminating outdated capacity [5][6] - The demand for viscose filament is anticipated to tighten, leading to an upward trend in prices, while the grass herbicide market is expected to optimize its structure [5][6] - The global GDP growth is projected to remain at 2.8%, with stable oil demand despite some slowdown due to tariff policies [5][6] Industry Dynamics - Oil supply is expected to increase significantly, driven by non-OPEC production, while demand remains stable [5][6] - The coal market is anticipated to experience long-term price stabilization, with easing pressures on downstream sectors [5][6] - Natural gas exports from the U.S. are likely to accelerate, potentially lowering import costs [5][6] Chemical Sector Analysis - The report highlights that the viscose filament industry will see a supply-demand tightening, with a projected increase in operating rates from 84% to over 95% [5][6] - The grass herbicide market is set to address issues of low pricing and quality through upcoming industry meetings aimed at regulating competition [5][6] Investment Recommendations - The report suggests focusing on sectors benefiting from the "anti-involution" policy, including textiles, agriculture, and export-related chemicals [5][6] - Specific companies to watch include Xinxiang Chemical Fiber, Jilin Chemical Fiber, and Lier Chemical, which are expected to benefit from market dynamics [5][6][20] Key Company Valuations - The report provides a valuation table for key companies, indicating various ratings such as "Buy" and "Increase" for companies like Hailir Chemical, Yunnan Chemical, and Wanhu Chemical [20]

证券代码：300596 证券简称：利安隆 公告编号：2025-065 天津利安隆新材料股份有限公司 2025 年第三次临时股东会决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记 载、误导性陈述或重大遗漏。 特别提示： 1. 本次股东会不存在增加、变更、否决议案的情形； 2. 本次股东会不存在变更前次股东会决议的情形； 3. 本次股东会以现场投票与网络投票相结合的方式召开。 一、 会议召开与出席情况 （一）会议召开情况 1. 会议召集人：天津利安隆新材料股份有限公司第五届董事会 2. 会议主持人：天津利安隆新材料股份有限公司董事长李海平先生 3. 现场会议召开时间：2025 年 9 月 15 日（星期一）下午 15:00。 1. 股东出席的总体情况： 通过现场和网络投票的股东及股东代表 74 人，代表股份 81,618,943 股，占 公司有表决权股份总数的 35.5453％。 其中：通过现场投票的股东及股东代表 5 人，代表股份 79,549,595 股，占 公司有表决权股份总数的 34.6441％。 4. 现场会议召开地点：天津市华苑产业区开华道 20 号 F 座 20 层天津利安 ...

北京市中伦律师事务所 关于天津利安隆新材料股份有限公司 2025 年第三次临时股东会的 法律意见书 二〇二五年九月 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty 北京市中伦律师事务所 关于天津利安隆新材料股份有限公司 2025 年第三次临时股东会的 法律意见书 致：天津利安隆新材料股份有限公司 北京市中伦律师事务所（下称"本所"）接受天津利安隆新材料股份有限公 司（下称"公司"）委托，指派本所律师见证了公司 2025 年第三次临时股东会， 并出具本法律意见书。 为出具本法律意见书，本所律师见证了公司 ...

Investment Rating - The investment rating for the company is "Outperform" (maintained) [1] Core Views - The company's performance met expectations, with stable growth in the anti-aging business and significant expansion in the lubricating oil additives segment [1][6] - The anti-aging agent business continues to expand, with a focus on increasing the proportion of high-end products and global market development [6] - The second phase of the Kangtai project is gradually releasing capacity, showing a clear trend of increasing volume and profit [6] - The life sciences business is moving towards market introduction, and the electronic-grade PI business is accelerating domestic and international integration [6] - The company has adjusted its profit forecasts for 2025-2027 due to competitive pressures, with expected net profits of 5.05 billion, 6.1 billion, and 7.15 billion respectively [6] Financial Data and Profit Forecast - Total revenue is projected to reach 6,095 million in 2025, with a year-on-year growth rate of 7.2% [2] - The net profit attributable to the parent company is expected to be 505 million in 2025, reflecting an 18.5% year-on-year growth [2] - Earnings per share are forecasted to be 2.20 yuan in 2025, with a gross margin of 21.9% [2] - The return on equity (ROE) is projected to be 10.4% in 2025 [2] Market Data - As of September 12, 2025, the closing price is 35.24 yuan, with a market capitalization of 7,860 million [3] - The price-to-book (PB) ratio is 1.8, indicating a relatively high safety margin compared to the historical average [3][6]

Investment Rating - The report maintains a "Positive" rating for the chemical industry [6][12]. Core Insights - The macroeconomic judgment indicates that non-OPEC countries are expected to lead an increase in oil production, with a significant overall supply growth anticipated. Global GDP growth is projected to remain at 2.8%, with stable oil demand, although the growth rate may slow due to tariff policies [6][7]. - The expectation of a Federal Reserve interest rate cut is likely to boost demand during the peak season of September and October. Additionally, the leakage incident of GFL R32 in India may enhance China's export opportunities [6][12]. - The report highlights the ongoing investigation into anti-dumping practices against imported semiconductor chips from the U.S., which may benefit domestic semiconductor materials [6][12]. Summary by Sections Macroeconomic Analysis - Oil supply is expected to increase significantly, driven by non-OPEC production, while demand remains stable despite potential slowdowns due to tariffs. Geopolitical factors, including U.S.-China tariff relief and the Russia-Ukraine situation, are influencing oil prices [6][7]. - Coal prices are anticipated to stabilize at a low level, and natural gas export facilities in the U.S. may accelerate, leading to lower import costs [6][7]. Chemical Sector Configuration - The report suggests a strategic focus on four areas: textile and apparel chain, agricultural chemicals, export chain, and sectors benefiting from "de-involution" policies. Specific companies are recommended for investment based on their market positions and growth potential [6][12]. Key Material Focus - Emphasis is placed on the importance of self-sufficiency in key materials, particularly in semiconductor and panel materials, with specific companies highlighted for their potential in these sectors [6][12]. Price Trends - Recent data indicates fluctuations in various chemical prices, with PTA prices down by 0.3% and MEG down by 2.0%. The report notes that the overall industrial product PPI has shown a year-on-year decline of 2.9% [12][13][16]. Company Valuations - A detailed valuation table is provided, showcasing various companies in the agricultural chemicals and chemical sectors, with ratings ranging from "Buy" to "Increase" based on their market performance and projected earnings [20].

Group 1 - The event "2025 Investor Online Collective Reception Day and Semi-Annual Performance Briefing" was held on September 11, focusing on listed companies in the Tianjin area [1] - Li Haiping, Chairman and President of Lianlong (300596), stated that the construction of the PI project is progressing as planned, with the main structure already topped out and equipment installation to follow [1] - The market introduction of PI products has commenced domestically, receiving recognition from customers [1]

Core Viewpoint - The company has achieved revenue and profit growth in the first half of 2025, demonstrating resilience against changes in the international business environment and maintaining a strategic focus [1] Financial Performance - In the first half of 2025, the company reported a revenue of 2.995 billion yuan and a net profit attributable to shareholders of 241 million yuan [1] - The net profit after deducting non-recurring gains and losses was 236 million yuan [1] Business Strategy - The company has maintained a compound annual growth rate (CAGR) of 24.59% in revenue over the past fourteen years [1] - The company employs a multi-business collaboration strategy involving "anti-aging agents + lubricant additives + life sciences" to enhance its risk resistance [1] - The company is actively planning a dual-track development model focusing on both product and capacity expansion overseas, promoting new products, new fields, and new production locations [1] Operational Focus - The company is accelerating its development in automation, information technology, and intelligence while ensuring the safety and health of its employees [1] - The company aims to achieve its annual "Big 3+1" goal through the collective efforts of all employees [1]

Core Viewpoint - The company is focusing on enhancing its global service capabilities through the construction of a project in Malaysia, aimed at meeting the increasing demand for anti-aging additives driven by the development of polymer materials [1] Group 1: Company Strategy - The chairman and president of the company, Li Haiping, emphasized that the Malaysian project is designed to better serve global customer product needs [1] - The company has established a comprehensive international marketing system to quickly serve international clients, reflecting its commitment to a dual circulation development strategy [1] Group 2: Market Demand and Performance - The company noted a consistent annual demand increase for anti-aging additives, aligning the Malaysian production capacity with downstream market needs [1] - The company's export revenue accounts for approximately 42%, indicating a significant reliance on international markets [1] Group 3: Investor Engagement - During the investor meeting, questions were raised regarding the conversion rate of orders obtained from international trade shows and the establishment of localized technical service centers in Southeast Asia [1] - The company is actively participating in international professional exhibitions to enhance its market presence and order conversion [1]

Group 1: Company Performance and Financials - The company's market capitalization increased from approximately 6.8 billion CNY on January 2, 2025, to about 8.0 billion CNY on September 11, 2025, reflecting a growth of approximately 17% [4] - In the first half of 2025, the company achieved a revenue of 2.995 billion CNY and a net profit of 241 million CNY, with a net profit margin improvement attributed to product structure optimization [9] - The company has maintained a compound annual growth rate (CAGR) of over 24% in revenue for more than 14 years [9] Group 2: Research and Development - The company reported a 17.18% increase in R&D expenditure in the first half of 2025, amounting to 144 million CNY, focusing on green transformation of light stabilizers [7] - The sales revenue from nucleic acid drug synthesis raw materials increased by 222.41% year-on-year in the first half of 2025 [3] Group 3: Market Strategy and Expansion - The company has established a complete international marketing system, with export revenue accounting for approximately 42% of total revenue [4] - The company aims to enhance its market position in the renewable energy sector by developing anti-aging agents for photovoltaic components and electric vehicle parts [3] Group 4: Production and Capacity - The company is progressing with the construction of its PI project, with the main structure already topped out and equipment installation underway [8] - The company’s new production line for antioxidants has achieved a significant capacity increase compared to traditional processes [3] Group 5: Environmental, Social, and Governance (ESG) - The company has initiated various projects to align with carbon neutrality goals, including green factory certifications and EHS data management [6] - The company’s environmental investment continues to maintain a leading position in the industry [6] Group 6: Talent and Management - The company has implemented multiple employee stock ownership plans to enhance talent retention and attract new talent [4] - The management team, primarily composed of individuals born in the 1980s, has taken over daily operations and innovation efforts [4]

Company Overview - Lianlong's stock price increased by 2.11% on September 11, reaching 35.32 CNY per share, with a trading volume of 78.93 million CNY and a turnover rate of 1.02%, resulting in a total market capitalization of 8.11 billion CNY [1] - The company specializes in the research, production, and sales of polymer material anti-aging chemical additives, with its main revenue sources being light stabilizers (36.68%), antioxidants (30.41%), lubricant additives (18.70%), U-pack (10.79%), and others (3.35%) [1] Financial Performance - For the first half of 2025, Lianlong achieved operating revenue of 2.995 billion CNY, representing a year-on-year growth of 6.21%, and a net profit attributable to shareholders of 241 million CNY, up 9.60% year-on-year [2] - Since its A-share listing, Lianlong has distributed a total of 450 million CNY in dividends, with 243 million CNY distributed over the past three years [3] Shareholder Information - As of June 30, Lianlong had 17,700 shareholders, a decrease of 0.29% from the previous period, with an average of 12,587 circulating shares per shareholder, down 0.45% [2]